Co-Authors
This is a "connection" page, showing publications co-authored by Jonathan Segal and Alexandra Kent.
Connection Strength
0.175
-
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. Aliment Pharmacol Ther. 2021 06; 53(11):1236-1240.
Score: 0.059
-
Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD. BMJ Open Gastroenterol. 2021 03; 8(1).
Score: 0.058
-
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021 04; 6(4):271-281.
Score: 0.058